Metformin Bioequivalence Study [Design Issues]

posted by AB661 – India, 2020-08-19 09:22 (36 d 01:05 ago) – Posting: # 21888
Views: 595

Dear Colleagues,

I need your advice please for Metformin Oral Solution. As per Orange book it have AB TE code.
Should BE required to support ANDA application?

Metformin has non-linear pharmacokinetics. There No OGD BE guidance for this product . Whether BE study should be conducted with 500 dose or 1000 mg dose.

I would be grateful if someone could guide me.

With regards
AB

Complete thread:

Activity
 Admin contact
21,072 posts in 4,394 threads, 1,468 registered users;
online 5 (1 registered, 4 guests [including 2 identified bots]).
Forum time: Thursday 10:27 CEST (Europe/Vienna)

Enlightenment is man’s emergence from his self-imposed nonage
for which he himself was responsible.
Nonage is the inability to use one’s own intellect
without the direction of another.    Immanuel Kant

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5